Resumo

MUNOZ, Oscar M. et al. Clinical practice guidelines for the prevention, early detection, diagnosis, treatment and follow up of dyslipidemia: cardiovascular risk assessment. Rev. Colomb. Cardiol. [online]. 2015, vol.22, n.6, pp.263-269. ISSN 0120-5633.  https://doi.org/10.1016/j.rccar.2015.04.009.

Aim: The treatment of dyslipidemia must be related with patient's individual risk. There are multiple functions for predicting cardiovascular risk; however, it is necessary to determine the most appropriate for being used in Colombian population. Methods: The CINETS alliance, endorsed by the Colombian Social Protection Ministry and Colciencias, reviewed the evidence available about the validity of cardiovascular risk evaluation methods in Colombian Population. Recommendations were generated using GRADE methodology. Population: General adult population with or at risk of dyslipidemia. Recommendations In primary prevention population, or without clinically evident cardiovascular disease, Framingham risk function recalibrated for Colombia must be used to calculate cardiovascular risk (Strong recommendation). In patients with an especial condition increasing cardiovascular risk, direct pharmacologic treatment must be used.

Palavras-chave : Hypercholesterolemia; Lipid; Treatment; Statins.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )